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Abstract: Cardiodiabesity has been used to define and describe the well-known 
relationship between type 2 Diabetes Mellitus (T2DM), obesity, the metabolic syndrome 
(MetS) and cardiovascular disease (CVD). The objective of this study was to perform a 
scientific literature review with a systematic search to examine all the cardiovascular risk 
factors combined and their relationship with adherence to the Mediterranean Diet 
(MedDiet) pattern as primary prevention against cardiodiabesity in a holistic approach. 
Research was conducted using the PubMed database including clinical trials, cross-sectional 
and prospective cohort studies. Thirty-seven studies were reviewed: fourteen related to 
obesity, ten to CVD, nine to MetS, and four to T2DM. Indeed 33 provided strong evidence 
on the association between adherence to a MedDiet and a reduced incidence of collective 
cardiodiabesity risk in epidemiological studies. This scientific evidence makes the MedDiet 
pattern very useful for preventive strategies directed at the general population and also 
OPEN ACCESS
Nutrients 2014, 6 3475 
 
highlights the need to consider all these diet-related risk factors and health outcomes 
together in daily primary care. 
Keywords: Mediterranean Diet; cardiodiabesity; systematic review; primary prevention; 
obesity; cardiovascular disease; diabetes mellitus; metabolic syndrome 
 
1. Introduction 
Cardiodiabesity is a hybrid term used to define and describe the well-known relationship  
between type-2 diabetes mellitus (T2DM), obesity, metabolic syndrome (MetS) and cardiovascular 
disease (CVD). Diabesity was first coined by former US Surgeon General C. Everett Koop [1] trying 
to explain that there were many risk factors to T2DM besides fatness. In 2008, in the British Journal of 
Cardiology [2], cardiologists started to mention the idea that diabetes should be viewed as a vascular 
disease from the outset. The term cardiodiabesity is not only useful to describe this framework but also 
to highlight the need to consider all the risk factors and health outcomes combined in clinical practice. 
More than 347 million people worldwide have T2DM. It is foreseen that it will be the seventh 
leading cause of death by 2030 [3]. As with T2DM, obesity has reached epidemic proportions globally; 
from 1980 to 2008 the prevalence of obesity has doubled in the world, and at least 2.8 million people 
die each year as a result of being overweight or obese [4]. Furthermore, CVD was the cause of three 
out of ten deaths, accounting for nearly 17 million deaths in 2011 [5]. 
Based on this global framework, the European Society of Cardiology-European Association for  
the Study of Diabetes (ESC-EASD) established the close relationship between hyperglycemia and 
microvascular disease in their guidelines. The clustering of vascular risk seen in association with 
insulin resistance has led to the view that cardiovascular risk appears early, prior to the development of 
T2DM. This fact highlights that patients with T2DM should be managed as patients with established 
atherosclerotic disease [6]. 
Moreover, the guidelines of the National Institute for Health and Clinical Excellence (NICE) 
recommend treatment of dyslipidemia as a key modifiable risk factor in patients with T2DM and  
CVD [7,8]. Furthermore, it is well known that in central obesity, visceral adiposity tissue dysfunction 
leads to T2DM and CVD through increased peripheral insulin resistance due to high serum insulin 
concentrations. This clustering of vascular risk factors (insulin resistance, visceral or abdominal 
obesity and dyslipidemia) among other factors (hypertension) shapes the metabolic syndrome  
(MetS) [9,10]. These metabolic disturbances have an impact not only on glucose metabolism and the 
cardiovascular system, but also on gout and systemic inflammation, and predispose pancreatic tissue to 
pre-diabetes or diabetes itself [11]. Management of obesity and prevention of CVD and T2DM should 
be aimed at reducing the overall risk in a holistic health prevention and management approach. 
There is substantial scientific evidence that diet plays an important role in the development of 
numerous chronic diseases. The Mediterranean Diet (MedDiet) has long been reported to be a prudent 
dietary pattern for non-communicable disease prevention [12–16], linked with nutritional  
adequacy [17] and has been promoted as a model of healthy eating based on its relation with 
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preserving a good health status and quality of life [12,13], mainly through its favorable effects on 
cardiovascular risk factors and ultimately, by reducing cardiovascular morbidity and mortality [13]. 
This dietary pattern as described in the Mediterranean Diet pyramid [18] is generally characterized 
by a high consumption of plant foods (such as fruit, vegetables, legumes, nuts and seeds and cereals, 
preferably wholegrain); the seasonal choice of fresh and locally grown produce as far as possible;  
the presence of fruit as the main daily dessert and olive oil as the main source of dietary lipids; 
moderate consumption of dairy products (mainly cheese and yoghurt); low to moderate amounts of 
fish, poultry and eggs; consumption of red meat at a low frequency and in small amounts; and a 
moderate intake of wine during meals. Regarding the nutritional value of the MedDiet, this dietary 
pattern is low in saturated and trans fats, with an optimal nutritional quality due to the presence of 
healthy fats from olive oil, nuts and fish, as well as complex carbohydrates, micronutrients, antioxidants, 
non-nutritive factors and, furthermore, its abundant fiber and varied plant-based composition with 
sufficient protein intake of both plant and animal origin. The MedDiet pattern also gathers a proper 
ratio between the macronutrients, low energy density and low glycemic index meals [18,19]. 
The dietary pattern analysis approach has been imposed over the single nutrient or food  
approach [20,21]. Many MedDiet indexes [21] have been developed to study the relationship between 
the MedDiet pattern and different health parameters. 
Not only the MedDiet has been stated as a health model, but also a cultural model after its 
recognition as an Intangible Cultural Heritage of Humanity by the United Nations Educational, 
Scientific and Cultural Organization (UNESCO) [22]. It is a culturally accepted and highly palatable 
dietary pattern that allows high compliance, food availability and affordability in the Mediterranean 
countries. Besides, the MedDiet pattern results in lower environmental footprints than the larger 
extended Western diet due to the greater emphasis on plant- over animal-derived products [23]. 
Among the scarce literature focused on evaluating the relationship between food costs and adherence 
to different food patterns [24], the MedDiet pattern is flexible and adjustable according to specific 
needs and preferences. Thus, the MedDiet is an extremely healthy, economically affordable and 
environmentally sustainable food model, especially in Mediterranean countries with a higher 
availability of MedDiet products. However, there has been a decrease in the adherence to the MedDiet 
in Mediterranean countries in the last decades [25–27], occurring in parallel to the “westernization” of 
the society (fast food, sedentary lifestyles, etc.). Although the relationship between these dietary and 
lifestyle changes and the increased prevalence of different illnesses has not been well established, there 
is a clear parallel trend between a higher prevalence of obesity, CVD or T2DM worldwide and the 
aforementioned changes in the dietary patterns of the population. 
Although reviews of each specific disease such as obesity, T2DM or CVD in relation to the 
MedDiet have been published [13,15,28–31], up to now no review of the clinical trials, cross-sectional 
and prospective cohort studies has been performed to examine all these risk factors combined and their 
relationship with the MedDiet. Therefore, the aim of this review was to introduce the term 
cardiodiabesity and systematically summarize scientific evidence concerning the association between 
adherence to the MedDiet and the collective cardiodiabesity risk in all the studies. 
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2. Materials and Methods 
The literature review was focused on prospective cohort, cross-sectional and clinical trial studies on 
the association between adherence to a MedDiet and cardiodiabesity, i.e., MetS, T2DM, obesity and 
CVD as primary prevention outcomes. We excluded case-control design studies because of their 
related high potential selection bias. 
A systematic search was conducted up to September 2013 through a computer-assisted published 
data search (PubMed; MEDLINE, National Library of Medicine, Bethesda, MD, USA). In PubMed, 
the MeSH terms used were “Mediterranean diet” along with other key words: “Diabetes Mellitus”, 
“Coronary Disease”, “Myocardial Ischemia”, “Heart Diseases”, “Metabolic Syndrome X”, and 
“Obesity”. The search was limited to human studies and restricted to articles in English. All studies 
with full text were considered. The initial search resulted in 740 articles. The search was then 
narrowed to include only articles examining the effect on the four outcomes (T2DM, obesity, CVD and 
MetS) as the main outcome and evaluating adherence to the MedDiet pattern as a whole. Studies 
focused on primary prevention of outcome events were selected. Additional publications were 
identified from references provided in original papers. The relevance of the studies was assessed with a 
hierarchical approach on the basis of title, abstract and the full manuscript. 
A total of 740 articles were selected with these Mesh terms and then analyzed. The topic 
distribution was 80 for MetS, 170 for obesity, 108 for T2DM and 382 for CVD. Among the original 
research articles, 523 were excluded on the basis of the title and including reviews. From the total  
of 217 articles and on the basis of abstracts, 122 were excluded, resulting in 95 articles: 11 on MetS, 
21 on obesity, 20 on T2DM and 43 on CVD. After reading the whole article, 37 were selected, 
resulting in the final inclusion of 14 studies on obesity, 9 on the MetS, 4 on T2DM and 10 on CVD 
(Figure 1). 
3. Results 
3.1. Characteristics of Study Sample 
Most of the studies were from Mediterranean countries, specifically in Southern Europe, except for 
three conducted in the USA [32–34], two in Canada [35,36] and three in European countries outside 
the Mediterranean area [37–39]. Most had been conducted in both men and women, three studies only 
included females [35,38,40] and three involved children or adolescents [41–43]. All the studies were 
published between 2003 and 2013. The health status of the subjects varied among studies, but in the 
current review only includes studies on primary prevention. 
  
Nutrients 2014, 6 3478 
 
Figure 1. Flow-chart of the selection process. Abbreviations are as follows: METS, metabolic 
syndrome; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease. 
 
The criteria of quality considered for the studies selected were the sample size, follow-up period 
and adjustment for potential confounders (demographic, anthropometric and traditional cardiovascular 
risk factors). Information regarding the methodology and weight-related results for these studies are 
summarized in Table 1. The sample sizes varied from 77 [35] and 497,308 [37] individuals. The 
potential confounders considered in the statistical analysis varied among studies, but the most common 
were age, sex, energy intake, smoking, physical activity and educational level, and also body mass 
index, marital status, family history of disease or pharmacological treatment. 
To assess adherence to the MedDiet pattern, most of the studies included used the Mediterranean 
diet score established in 2003 by Trichopolou et al. [44,45], albeit with some modifications in many 
studies (detailed on Table 1). In addition, a considerable number of studies established their own score, 
for instance in the PREDIMED trial [46] the score for adherence to the MedDiet is based on  
a 14-item index. 
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Table 1. Characteristics of the studies included evaluating the relationship between the Mediterranean Diet and cardiodiabesity. 
Author/Year of 
Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index 
Main 
Outcome
Results Confounders 
Panagiotakos et al. 
2005 [47] 
Greece 
♂1514  
♀1528 
♂20–87;  
♀20–89 
1.25 3042 
Score based on dietary pyramid [48]: 
(d) non refined cereals and products, 
fruits, olive oil, dairy products, wine; 
(w) fish, poultry, potatoes, olives, 
legumes, nuts, eggs, sweets;  
(m) red meat 
T2DM 
With 10 P increase score:  
OR 0.79 (95% CI 0.65–0.94), p < 0.05);  
ARR 1.3% (5.6%–4.3%);  
RRR 23.2% [(5.6%–4.3%)/5.6%] 
Age, sex, BMI, WC, hc, 
education, financial 
status, smoking, family 
history of T2DM 
Martínez-Glez et al.
2008 [49] 
Spain 
Men and 
women 
20–90 4.4 13,380 
MDS [45]: (+) fatty acid ratio, 
legumes, grains, fruits, vegetables, 
fish, wine; (−) dairy products or meat 
T2DM 
OR 0.41 (95% CI 0.19–0.87) (score 3–6);  
OR 0.17 (0.04–0.75) (score 7–9).  
With 2 P increase score  
RR 0.65, (0.44–0.95), p = 0.04 
Sex, age, years of 
university education, TEI, 
BMI, PA, sedentary 
habits, smoking, family 
history of T2DM, and 
personal history of HT 
Salas-Salvadó et al.
2011 [50] 
Spain 
Men and 
women 
55–80 4 418 
PREDIMED score 14 items [51]:  
olive oil, vegetables, fruit, fatty acid 
ratio, legumes, wine, fish, nuts;  
(−) sweets and carbonated beverages, 
red meat 
T2DM 
T2DM incidence MedDiet VOO 10.1%  
(95% CI 5.1–15.1), MedDiet nuts 11.0%  
(5.9–16.1), control group 17.9% (11.4–24.4). 
MedDiet VOO OR 0.49 (0.25–0.97) and nuts 
groups 0.48 (0.24–0.96).  
DM incidence was reduced 52% (27–86) 
Age, sex, TEI, BMI, WC, 
PA, smoking status, 
fasting serum glucose, 
use of lipid lowering 
drugs, MedDiet score, 
and weight change during 
the study 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index 
Main 
Outcome
Results Confounders 
Abiemo et al.  
2013 [33] 
USA 
Men and 
women 
45–84 6 5390 
Score was created [45]: vegetables, 
whole grains, nuts, legumes, fruits, 
MUFA/SFA, red and processed meat, 
dairy products, fish, OH 
T2DM 
MeDiet score: lower baseline mean insulin levels, 
Q1: 5.8 (95% CI 5.6–6.0) μmol/L;  
Q5: 4.8 (95% CI 4.6–5.0) μmol/L; p < 0·0001. 
MedDiet not significantly related risk of T2DM  
p = 0.64 
Demographic, 
physiological and 
behavioral characteristics 
Panagiotakos et al. 
2004 [52] 
Greece 
Men and 
women 
>18 / 2282 
Score created [53]: (d) cereals and 
products, vegetables, fruits, olive oil, 
dairy products; (w) fish, poultry, 
olives, legumes, nuts, potatoes, eggs, 
sweets; (m) red meat; (+m) wine and 
high MUFA/SFA ratio 
MetS OD 0.81 (95% CI, 0.68–0.976) 
Age, sex, PA, education, 
smoking, BMI, diet in the 
past 12 months, TEI 
Álvarez-León et al. 
2006 [54] 
Spain 
Men and 
women 
>18 / 578 
10-Item score created [55]: cereal, 
fruits, vegetables, legumes, fish, nuts, 
alcohol intake from red wine, 
MUFA/SFA and dairy products 
MetS 
MD adherence not related to MetS prevalence;  
T2 OR 1.39 (95% CI, 0.75–2.59);  
T3 OR 1.37 (95% CI, 0.76–2.46) 
Age, sex, PA, education, 
smoking, BMI, diet in the 
past 12 months, TEI 
Tortosa et al.  
2007 [56] 
Spain 
Men and 
women 
20–90 6 2563 
MDS [44]: (+) fatty acid ratio, 
legumes, grains, fruits, vegetables, 
fish, wine; (−) dairy products or meat. 
MetS 
MFP (95% CI) Age & sex adjusted  
score 3–5 OR 0.76 (0.40–1.45);  
score 6–9 OR 0.18 (0.06–0.56) p = 0.006; 
Multivariate-adjusted  
score 3–5 OR 0.80 (0.42–1.54);  
score 6–9 OR 0.20 (0.06–0.63) 
Age, sex, PA,  
smoking, TEI 
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Table 1. Cont. 
Author/year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index 
Main  
Outcome 
Results Confounders 
Salas-Salvadó et al. 
2008 [57] 
Spain 
Men and 
women 
♂55–80;  
♀60–80 
1 1224 
PREDIMED score 14 items [51]: 
olive oil, vegetables, fruit, fatty  
acid ratio, legumes, wine, fish,  
nuts; (−) sweets and carbonated 
beverages, meat 
MetS 
MedDiet VOO group OR 1.3 (95% CI 0.8–2.1);  
MedDiet nuts group OR 1.7 (1.1–2.6) 
Sex, age, baseline obesity 
status, and weight changes 
Babio et al.  
2009 [58] 
Spain 
Men and 
women 
Mean 67 / 808 
14-P questionnaire [59]: olive oil, 
vegetables, fruit, fatty acid ratio, 
legumes, wine, fish, nuts; (−) sweets 
and carbonated beverages, meat 
MetS ↑MD score OR 0.44 (95% CI, 0.27–0.70) 
Age, sex, PA,  
smoking, TEI 
Bibiloni et al.  
2011 [43] 
Spain 
Men and 
women 
12–17 / 362 
Score created [45]: high MUFA/SFA 
ratio; (+m) OH, high legume, cereals 
and roots, fruit, vegetables, and fish 
consumption, and low meat and milk 
consumption 
MetS 
Q2 MD 6.9%; Q4 5.9%;  
Glucose levels 0.89 (95% CI 0.40–1.90),  
triglyceride levels 0.72 (95% CI 0.31–1.77) and  
HDL-cholesterol levels 0.43 (95% CI 0.19–0.99) 
Sex, age, parental 
educational level,  
parental socioeconomic 
status and PA 
Rumawas et al.  
2009 [34] 
EEUU 
Men and 
women 
Mean 54 7 2730 
Score created based on MSDPS [60]: 
whole-grain cereals, fruit, vegetables, 
dairy, wine, fish, poultry, 
olives/legumes/nuts, potatoes, eggs, 
sweets, meat, and olive oil 
MetS 
Q5 MSDPS ↓ incidence MetS (38.5% vs. 30.1%;  
p = 0.01) (95% CI) HOMA-IR Q5 3.16 (3.03–3.30) 
p = 0.02; fasting glucose 97.1 (96.3–98.0) p = 0.03; 
waist circumference 97.1 (96.7–97.6) p < 0.001; 
triglycerides 103 (99–107) p < 0.001;  
HDL-cholesterol 54.0 (53.1–55.0) p = 0.02 
Height, weight, BMI, age, 
sex, smoking, multivitamin 
use, ERT, PA, TEI 
  
Nutrients 2014, 6 3482 
 
Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-up 
(Years) 
N Components in the MD Index 
Main 
Outcome 
Results Confounders 
Paletas et al.  
2010 [61] 
Greece 
Men and 
women 
44.4 ± 13.35 / 226 
MDS [45]: (+) fatty acid ratio, 
legumes, grains, fruits, vegetables, 
fish, wine; (−) dairy products  
or meat 
MetS 
MetS components ↑ non-MD: MetS prevalence 
27.3% MedDiet group, 60.2% HF group, and  
HC group 69.2% p = 0.006 
Sex, BMI, TEI 
Kesse-Guyot et al. 
2013 [62] 
France 
Men and 
women 
>18 6 3232 
MDS [45], MSDPS [60] and  
MED [63] 
MetS 
↓ MetS: high MED OR 0.47 (95% CI 0.32–0.69)  
p = 0.001; high MDS OR 0.50 (95% CI 0.32–0.77) 
p = 0.03 
Age, gender, education 
level, smoking status, 
PA, TEI, antidiabetic, 
antihypertensive and lipid 
lowering medications 
Goulet et al.  
2003 [35] 
Canada Women 30–65 0.25 77 
MD: (+) cereals, fruit, vegetables, 
legumes, nuts and seeds, fish, olive 
oil, wine; (−) dairy products, 
chicken, eggs, sweets, red meat 
OW and OB
↑ MD, ↓ BMI (mean week 0: 25.8 ± 3.9 kg/m2 to 
mean week 3 25.6 ± 3.8 kg/m2) p < 0.01; adh less 
weight (m0: 67.7 ± 11.9 kg to m3: 67.3 ± 11 kg)  
p < 0.01 
 
Schröder et al. 
2004 [64] 
Spain 
♂1403  
♀1468 
25–74 2 3162 
MDS [44]: (+) cereals, vegetables, 
fruit, legumes, nuts, fish, red wine; 
(−) meat, high fat dairy products 
OB 
↑ MD, ↓ OB OR 0.61 p = 0.01;  
With 5-P MD, less BMI ♂ −0.43 kg/m2 p = 0.030; 
♀ −0.68 kg/m2 p = 0.007 
Age, TEI, educational 
level, smoking, LTPA, 
smoking and alcohol 
consumption 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age 
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index 
Main 
Outcome 
Results Confounders 
Trichopoulou et al. 
2005 [65] 
Greece 
♂9612  
♀13,985 
20–86 / 23,597 
MDS [44]: (+) cereals, vegetables, 
fruit and nuts, legumes, fish, 
MUFA/SFA; (+m) OH; (−) meat 
and dairy products 
OB 
With 2 P increase score controlling TEI  
♂ OR 0.08 (95% CI −0.03–0.20),  
♀ OR −0.06 (95% CI −0.16–0.04);  
With 2 P increase score without controlling TEI 
♂ OR 0.21 (95% CI 0.10–0.32),  
♀ OR 0.05 (95% CI −0.04–0.15) 
Age, years of schooling, 
smoking, PA, TEI 
Shubair et al.  
2005 [36] 
Canada
♂265  
♀494 
18–65 / 759 
MDP score created: (+) fruit, 
vegetables, olive oil and garlic, 
fish and shellfish; (−) meats and 
poultry, high SFA, foods high in 
added sugar and low nutrients 
OB 
↑ MD, ↓ BMI (β-coefficient −0.186)  
p = 0.027 
Sex, education, income and 
marital status 
Panagiotakos et al. 
2006 [66] 
Greece 
♂1514  
♀1528 
18–89 / 3042 
MDS [48]: wholegrain cereals, 
vegetables, fruit, legumes, fish, 
olive oil, dairy products, chicken, 
nuts and seeds, olives, potatoes, 
eggs, sweets, meat, MUFA/SFA 
OW and 
OB 
With 5 P increased score OR 0.49  
(95% CI 0.42–0.56) (OB & OW);  
↑ MD, ↓ BMI (−4 kg) p = 0.001 
Age, sex, PA, metabolism, 
educational level, smoking status 
Mendez et al.  
2006 [67] 
Spain 
♂10,589 
♀17,238 
29–65 3.3 27,827 
MDS [65]: (+) cereals, vegetables, 
fruit, legumes, fish, MUFA/SFA; 
(+m) OH; (−) meat 
OB 
S OW subjects ♀ OR 0.73 (95% CI 0.57–0.93),  
♂ OR 0.71 (95% CI 0.55–0.93);  
NS OW subjects ♀ OR 0.99 (95% CI 0.78–1.25), 
♂ OR 1.11 (95% CI 0.81–1.52) 
Age, special diets related to 
obesity or related disorders, 
categorical activity index, 
education, center, height, parity, 
smoking status, winter season, 
follow-up time, health status and 
changes in lifestyle or health 
during follow-up 
  
Nutrients 2014, 6 3484 
 
Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age 
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index Main Outcome Results Confounders 
Andreoli et al.  
2008 [40] 
Italy Women 25–70 0.33 47 
MD moderately hypo-caloric:  
(+) vegetables, fruit, pasta, bread, 
legumes, fish, olive oil, red wine, 
meat, dairy products & PA program 
Cardiovascular 
disease risk factors 
in obese women 
↑ MD, ↓ weight (m0 80.4 ± 15.8 kg to 
m4 75.2 ± 14.7 kg) p < 0.001;  
↑ MD, ↓ BMI (m0 30.7 ± 6.0 kg to  
m4 28.7 ± 5.6 kg) p < 0.001 
 
Panagiotakos et al. 
2007 [68] 
Cyprus 
♂53  
♀97 
65–100 / 150 
MDS: wholegrain cereals, vegetables, 
fruit, legumes, fish, olive oil, dairy 
products, chicken, nuts, seeds, olives, 
potatoes, eggs, sweets, meat 
OB 
With 10 P increased score OR 0.83  
(95% CI −0.25–0.12) p < 0.001 
(having one additional risk factor); 
With 10 P increased score 12% lower 
OR OB p = 0.001 
Age, sex, smoking  
habits, PA 
Romaguera et al. 
2009 [37] 
10 European 
countries 
Men and 
women 
25–70 8 497,308 
mMDS [44]: (+) vegetables, legumes, 
fruits, nuts, cereals, fish and seafood, 
MUFA/SFA; (+m) OH; (−) meat, 
dairy products 
OB 
↑ MD, ↓ WC, for a given BMI  
♂ 20.09 (95% CI 20.14–20.04),  
♀ 20.06 (95% CI 20.10–20.01);  
Northern European countries  
♂ 20.20 (95% CI 20.23–20.17),  
♀ 20.17 (95% CI 20.21–20.13) 
Age, educational level 
(categorical), PA, 
smoking status, height, 
menopausal status 
Beunza et al.  
2010 [69] 
Spain 
Men and 
women 
Mean 38 5.7 ± 2.2 10,376 MDS [45] OW and OB 
↑ MD, ↓ weight 20.059 kg/year  
95% CI 20.111–20.008 kg/year,  
p = 0.02; lowest risk weight gain  
4-year 0.76 (95% CI 0.64–0.90) 
Age, sex, baseline BMI, 
PA, sedentary behaviors, 
smoking, between-meals 
snacking, TEI 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N 
Components in the  
MD Index 
Main 
Outcome 
Results Confounders 
Romaguera et al. 
2010 [70] 
10 European 
countries 
Men and 
women 
25–70 5 373,803 
rMED [71]: (+) vegetables, 
legumes, fruit, nuts, cereals, 
fish and seafood, olive oil; 
(+m) OH; (−) meat, dairy 
products 
OW & OB 
↑ rMED, ↓ weight gain 5-year 20.16 kg  
(95% CI 20.24, 20.07 kg); less likely to  
OW or OB 10% (95% CI 4%–18%) 
Sex, age, baseline BMI, 
follow-up, educational level, 
PA, smoking status, 
menopausal status, TEI, 
misreporting of TEI 
Lazarou et al.  
2010 [41] 
Cyprus 
Men and 
women 
Mean  
10.7 ± 0.98
/ 1140 KIDMED [72] OB 
↑ KIDMED, ↓ likely to OW/OB 80%  
(95% CI 0.041–0.976) 
Age, gender, parental obesity 
status, parental educational 
level, dietary beliefs and 
behaviors 
Farajian et al.  
2011 [42] 
Greece Children 10–12 / 4786 KIDMED [72] OW & OB 
NS NW (score mean 3.70 ± 2.26) & OW/OB 
(score mean 3.62 ± 2.26), t-test 1.08, p = 0.28
Age, BMI, waist, body  
fat mass 
Martínez-Glez et al. 
2012 [73] 
Spain 
Men and 
women; 
57%♀ 
55–80 / 7447 PREDIMED [51] OB 
With 2 P increase score  
♀ WHtR OR −0.65 (95% CI −0.87–0.48),  
BMI OR −0.37 (95% CI −0.50–0.24),  
WC OR −0.92 (−1.26–0.58);  
♂ WHtR OR −0.58 (95% CI −0.79–0.38),  
BMI OR −0.25 (95% CI −0.37–0.13),  
WC OR −0.93 (95% CI −1.29–0.58) 
Age, smoking, diabetes 
status, HT status, PA, 
educational level, marital 
status, center, TEI 
Trichopoulou et al. 
2003 [45] 
Greece 
Men and 
women 
20–86 Median 3.7 22,043 
9 Unit MDS [44]:  
(+) vegetables, legumes, 
fruits, nuts, cereals, fish;  
(+m) OH; (−) meat, poultry, 
dairy products 
Fatal CHD 
events 
↑ MD, ↓ CHD mortality HR 0.67  
(95% CI 0.47–0.94) 
Sex, age, years of education, 
smoking status, WtHR, BMI, 
TEI, energy-expenditure score 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age 
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index
Main 
Outcome 
Results Confounders 
Knoops et al.  
2004 [39] 
11 European 
Countries 
Men and 
women 
70–90 12 2339 
mMD [45]: MUFA/SFA, 
legumes, nuts, seeds, grains, 
fruit, vegetables and potatoes, 
meat, dairy products, fish 
All-cause and 
cause specific 
mortality 
↑ MD score, ↓ mortality: all causes  
0.77 (0.68–0.88), CHD 0.61 (0.43–0.88),  
CVD 0.71 (0.58–0.88) (95% CI) 
Other diet and lifestyle 
factors, sex, age at baseline, 
BMI, and study population 
(SENECA vs. FINE). 
Panagiotakos et al. 
2007 [74] 
Greece 
Men and 
women 
18–89  3042 
Own score [48]: (+) non-refined 
cereals, fruit, vegetables, 
legumes, potatoes, fish, olive oil; 
(−) meat, poultry, full fat dairy 
products; (+m) OH 
CVD risk 
factors 
With 10 P increase score, 10-year follow up 
4% lower CHD risk (±0.1%, p < 0.001);  
↑ MD, ↓ 10-year follow up CHD risk  
(rho −0.7, p < 0.001) 
No assessment for 
potential confounding since 
all analyses were unadjusted 
Buckland et al. 
2009 [71] 
Spain 
Men and 
women 
29–69 Mean 10.4 41,078 
r-MED [45]: (+) fruits, nuts, 
seeds, vegetables (no potatoes), 
legumes, cereals, fresh fish, 
olive oil; (−) meat, dairy products
CHD events 
↑ MD score, ↓ CHD risk,  
Z ¼ 0.60 (95% CI 0.47–0.77);  
with 1 P increase score, 6% reduced risk  
CHD (95% CI 0.91–0.97) 
Age, BMI, educational 
level, smoking status,  
PA, TEI, T2DM, 
hyperlipidemia, HT 
Fung et al. 
2009 [38] 
U.K. Women 38–63 20 74,886 
aMED [45]: (+) vegetables 
(excluding potatoes), fruits, 
nuts, whole grain, legumes,  
fish, MUFA/SFA; (+m) OH;  
(−) meat 
Risk of stroke
Q5 ↓, risk CHD RR 0.71 (95% CI 0.62–0.82), 
p = 0.0001 for CHD;  
↓ risk stroke RR 0.87 (95% CI 0.73–1.02),  
p = 0.03;  
Q5, ↓ CVD mortality ♀ RR 0.61  
(95% CI 0.49–0.76), p = 0.0001 
Age, smoking, BMI, 
menopausal status, 
postmenopausal hormone 
use, TEI, multivitamin 
intake, OH intake, family 
history, PA, aspirin 
Gardener et al. 
2011 [32] 
EEUU (NY)
Men and 
women 
69 ± 10 9 2568 
Own MD Score [45]: dairy, 
meat, fruit, vegetables 
(excluding potatoes), legumes, 
cereals (refined and whole), fish
CHD events 
Q5 score  
(1) HR 0.75 (95% CI 0.56–0.99) p = 0.04;  
(2) HR 0.80 (0.60–1.06) p = 0.10.  
With 1P increase score  
(1) HR 0.94 (0.89–1.00),  
(2) HR 0.95 (0.90–1.01) 
(1) Age, sex, ethnicity, 
education, PA, TEI, 
smoking; (2) model 1  
and T2DM, HT, 
hypercholesterolemia, 
history self-reported  
cardiac disease 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index 
Main 
Outcome
Results Confounders 
Martínez-Glez et al. 
2011 [75] 
Spain 
Men and 
women 
Mean 38 4.9 13,609 
9-Point score [45]: (+) MUFA/SFA, 
legumes, cereals, fruits, nuts, 
vegetables, fish; (+m) OH;  
(−) total dairy products, meat 
CHD 
events 
↑ MD, ↓ CVD risk HR 0.41 (95% CI 0.18–0.95); 
with 2 P increase score,  
total CVD HR 0.80 (95% CI 0.62–1.02),  
CHD HR 0.74 (95% CI 0.55–0.99) 
Age, sex, TEI, family 
history CHD, smoking, 
PA, baseline BMI, HT  
or use of medication, 
aspirin, baseline T2DM, 
baseline dyslipidaemia 
Menotti et al.  
2012 [76] 
Italy 
Men and 
women 
45–64 5 1139 
MAI [77]: (+) cereals, legumes, 
potatoes, vegetables, fresh dry fruit, 
fish, wine, virgin olive oil; (−) milk, 
cheese, meat, eggs, animal fats and 
margarines, sweet beverages, sugar 
CHD 
events 
20-Year follow-up lnMAI  
HR 0.74 (95% CI 0.56–0.98) p =0.0338;  
40-year follow-up lnMAI  
HR 0.79 (95% CI 0.65–0.96) p = 0.0168 
Age, cigarette smoking, 
systolic blood pressure, 
serum cholesterol, PA, BMI 
Guallar-Castrillón et al. 
2012 [78] 
Spain 
Men and 
women 
29–69 
8–12;  
median 11
40,757 Own score 
CHD 
events 
MD score HR  
Q2 0.77 (95% CI 0.61–0.98),  
Q3 0.64 (95% CI 0.50–0.83),  
Q4 0.56 (95% CI 0.43–0.73),  
Q5 0.73 (95% CI 0.57–0.94) 
Age, sex, BMI, WC, 
educational level, smoking, 
PA at work, home and 
leisure time, T2DM, HT, 
hypercholesterolemia, 
cancer, oral contraceptives, 
menopausal status, 
hormone replacement 
therapy, TEI 
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Table 1. Cont. 
Author/Year  
of Publication 
Country Gender 
Age  
(Years) 
Follow-Up 
(Years) 
N Components in the MD Index
Main 
Outcome 
Results Confounders 
Estruch et al. 
2013 [46] 
Spain 
Men and 
women 
55–80 4.8 7447 PREDIMED [51] CHD events 
MD VOO HR 0.70 (95% CI 0.54–0.92);  
MD nuts HR 0.72 (95% CI 0.54–0.96) 
Sex, age, BMI,  
cardiovascular-risk-factor status, 
baseline adherence MedDiet 
MD, Mediterranean Diet; ♂ men; ♀ women; MUFA/SFA, ratio of monounsaturated to saturated fat; Meat, meat and meat products; Dairy, milk and dairy products; (+), positive components;  
(−), negative components; (+m), components positive in moderation; (d) daily; (w) weekly; (m) monthly; adh, adherence; HR, hazard ratio; OH, alcohol consumption; PA, physical activity; TEI, total energy intake;  
WC, waist circumference; hc, hip circumference; HT, hypertension; CI, confidence interval; OR: odds ratio; BMI, body mass index; T2DM, type 2 diabetes mellitus; ARR, absolute risk reduction; RRR, relative 
risk reduction; Q, quartile; P, points; p for trend; MetS, metabolic syndrome; MDS, Mediterranean diet score; MED, Mediterranean score; MSDPS, Mediterranean style-dietary pattern score;  
HC, high-carbohydrate diet group; HF, high-fat diet group; T, tertile; mMDS, modified-Mediterranean Diet Score; rMED, Mediterranean Diet Score; LTPA, leisure-time physical activity; OW, overweight;  
NW, normal weight; S, significant; NS, not significant; WHtR, waist-to-height ratio; CHD, coronary heart disease; ACS, acute coronary syndrome; MAI, Mediterranean Adequacy Index; DM, diabetes mellitus; 
VOO, virgin olive oil; CVD, cardiovascular disease; 10 European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, the United Kingdom). 
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3.2. Association between the MedDiet and Cardiodiabesity 
Out of the 37 studies, 33 reported a significant association between adherence to MedDiet and 
reduced incidence and prevalence of cardiodiabesity, but in four there was no association between 
MedDiet, T2DM, obesity, MetS and CVD [33,37,54,65]. Figure 2 describes the overall diet-related 
cardiodiabesity parameters and cardiovascular risk factors used in the different studies reviewed. 
Figure 2. Diet-related Cardiodiabesity diagnostic parameters. Abbreviations are as follows: 
METS, metabolic syndrome; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; 
WC, waist circumference; BMI, body mass index. 
 
Regarding the association between adherence to the MedDiet pattern and T2DM, Abiemo et al. [33] 
reported that a greater consistency with a MedDiet style was cross-sectionally associated with lower 
serum insulin concentrations among non-diabetics and with lower blood glucose before adjustment for 
obesity but not with a lower incidence of DM. However, three out of the four studies selected found 
that a higher MedDiet score was predictive of a lower incidence of T2DM [47,49,50]. The greatest 
relative reduction in T2DM risk (52%) was observed in the PREDIMED nutritional intervention trial 
in subjects at high CVD risk who showed high adherence to the traditional MedDiet [50].  
The incidence of T2DM was reduced by 35% in the cohort study of Martínez-González et al. [49] in 
association with a two-point increase in the Trichopoulou score, adjusting for confounders. 
Panagiotakos et al. [47] described that a 10-unit increase in the diet score was associated with 21% 
lower odds of T2DM, while the combination of greater adherence to the MedDiet and light physical 
activity reduced the risk of diabetes by 35% after adjustment for various factors. 
The impact of the MedDiet pattern on the prevalence of the MetS was evaluated in five  
cross-sectional studies selected in this review [43,52,54,58,61]. In all these studies, the MetS criteria 
were defined according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel 
(ATP) III [79], which includes hypertriglyceridemia, low HDL-cholesterol, hypertension, hyperglycemia 
and central obesity. People who fulfilled three or more of these conditions were defined as having 
MetS. Alvarez-León et al. [54] concluded that MedDiet adherence was not related to MetS prevalence 
even though some components of the MedDiet showed a protective effect on the MetS and  
its components. The ATTICA study [52] determined that the odds ratio of having MetS decreased 
when the participants consumed a MedDiet and reported little-to-moderate physical activity. Other  
Nutrients 2014, 6 3490 
 
cross-sectional studies reported significant inverse associations between high adherence to the MetDiet 
and the prevalence of MetS criteria in elderly men with high CVD risk [58], in adolescents [43] and in 
overweight/obese subjects [61], respectively. Moreover, the three cohort studies selected, with a 
follow-up of 6 to 7 years, found the lowest incidence of MetS in subjects with the highest adherence to 
the MedDiet [34,56,62]. In addition, the overall prevalence of MetS at the first year assessment of the 
PREDIMED cohort showed a higher reduction in participants who consumed a MedDiet supplemented 
with mixed nuts compared with patients given advice to follow a low-fat diet [57]. It should be noted 
that in some studies individual components of the MetS, especially hyperglycemia, were not always 
significantly affected [56,57,62]. 
Most of the studies selected showed that the prevalence of overweight, obesity and central obesity 
was inversely associated with the MedDiet score. Classified according to study type, three cohort 
studies [67,69,70] reported that adherence to a MedDiet pattern was significantly associated with a 
reduced weight gain, and that the risk to develop overweight and obesity was also less likely. 
Specifically, Mendez et al. [67] reported a decrease in obesity with MedDiet adherence, albeit only 
being significant among the overweight population. All the interventional dietary studies [35,40,73] 
found that adherence to a MedDiet significantly decreased weight/BMI and, specifically, abdominal 
obesity. Regarding the cross-sectional studies, the EPIC-PANACEA study by Romaguera et al. [37] 
found that higher adherence to the MedDiet was significantly associated with lower abdominal 
adiposity for a given BMI, measured by waist circumference, while the MedDiet was not  
significantly associated with general obesity (BMI). Tripocholou et al. [65] did not find any 
association between MedDiet adherence and weight either. In contrast, five of the seven cross-sectional 
studies [36,41,64,66,68] found that greater adherence to a MedDiet had a significantly negative 
association with overweight/obesity. The strongest association was reported in the ATTICA study by  
Panagiatakos et al. [66] who found that individuals with high MedDiet adherence were 51% less likely 
to have both central adiposity and obesity, after adjustment for potential confounders. Note that in the 
CYKIDS study by Lazarou et al. [41] although adherence to the MedDiet was inversely associated 
with childhood obesity, when physical activity was taken into account, this relationship became less 
significant. Furthermore, children with higher adherence to a MedDiet reported to practice higher 
physical activity levels [42]. 
All the studies on the primary prevention of CVD showed a statistically significant association 
between the MedDiet pattern and the incidence of CVD [32,38,39,45,46,71,74–76,78]. In the 
PREDIMED trial, the largest randomized trial aimed to assess the effect of a dietary intervention using 
MedDiet on CVD outcomes; Estruch et al. [46] found that among persons at high cardiovascular risk, 
a MedDiet supplemented with extra-virgin olive oil or mixed nuts reduced the incidence of major 
cardiovascular events by 30%. Regarding cohort studies, adherence to the MedDiet was associated 
with a lower risk of coronary heart disease (CHD) in the large Spanish cohort of the EPIC  
study [71,75,78]. This MedDiet association has been assessed by either by using a priori [71,75] or  
a posteriori scales [78] during a median follow-up period of 10 years. The longest follow-up period 
was conducted in the Italian cohort study by Menotti et al. [76] in which individuals with a higher 
adherence to the MedDiet showed a protective effect against the occurrence of fatal CHD events  
at 20 and 40 years (CHD mortality reduction of 26% and 22%, respectively). Additionally, 
Tripochoulou et al. [45] (from the Greek cohort of the EPIC study) reported that the MedDiet was 
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associated with a significant reduction in mortality due to CHD. Moreover, an inverse association with 
greater adherence to a MedDiet was observed for all-cause mortality and cause-specific death such as 
CHD and CVD [39], lower risk of stroke [38] and other vascular events, such as myocardial infarction 
and vascular death [32]. 
4. Discussion 
This review is focused on the potential beneficial role of a MedDiet pattern for overall primary 
cardiodiabesity prevention taking into account the most solid, epidemiological and updated scientific 
evidence available. Several reviews have previously reported the beneficial effect of the MedDiet on 
obesity [30], T2DM, MetS [80] and CVD [81] risk factors. In this review, cardiodiabesity is 
considered as a term that embodies the overall diet-related diseases, which are the first causes of death 
worldwide, as well as others that affect and worsen health conditions. 
Of the 37 studies reviewed in this report, 33 provided strong evidence on the association between 
adherence to a MedDiet and CDV, T2DM, MetS and obesity. Moreover, results from the large scale 
randomized intervention study, the PREDIMED trial, have pointed out that after 5 years of 
intervention among high-risk persons who were initially free of CVD, a MedDiet (with no caloric 
restriction) supplemented with one daily serving of mixed nuts or up to 50 mL of extra-virgin olive oil 
reduced the incidence of three major cardiovascular events (cardiovascular death, myocardial 
infarction and stroke) [46] by 30%, suggesting a higher protective effect against cardiovascular risk 
factors with a MedDiet compared to a low-fat diet, with the added strength of higher compliance 
among the followers of the MedDiet [46,51]. This protective effect of the MedDiet observed appears 
early after starting the dietary change and is similar to the effects of statin and antihypertensive drug 
treatments but without side effects. In addition, the Portfolio diet described by Jenkins and colleagues, 
which comprised four key components as foods rich in soluble fiber, soy protein, plant sterols and 
almonds, reported a 29% reduction in LDL-cholesterol comparable to that observed with a small dose 
of a statin [82]. 
To increase the quality and level of scientific evidence, in this review we included prospective 
observational cohorts and clinical trials. Case-control studies were excluded because of the related bias 
as mentioned. Nevertheless, the results among the studies reviewed were not completely consistent. 
Romaguera et al. [37] and Trichopoulou et al. [65] found no significant relationship between 
adherence to a MedDiet and BMI, but they did find a relationship with a lower waist circumference for 
a given BMI in both genders. Abiemo et al. [33] reported that higher adherence to MedDiet was 
associated with lower insulin concentrations even though it did not decrease the incidence of  
T2DM, and the MeDiet also showed protective effects on some MetS components although the 
Alvarez et al. [54] study did not fulfill the conditions that—according to NCEP-ATPIII criteria—more 
than three components have to be present to diagnose MetS. Thus some studies reported no clear 
association between adherence to a traditional MedDiet and main outcomes although they did find 
positive associations with intermediate risks factors [33,37,54,65]. The variability of the associations 
observed and the strength between adherence to a MedDiet and cardiodiabesity could also be linked to 
several aspects and limitations inherent to differences between studies and samples. Similarly, other 
potential limitations were adjustments for different confounders and indexes used as described in the 
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table. Moreover, specifically designed studies should be carried out to assess these outcomes 
simultaneously in order to determine the synergy of interventions in several health parameters involved 
in cardiodiabesity. 
According to the American Public Health Association (APHA), in the USA obesity has about  
152 billion dollars/year and 73 billion dollars/year in direct and indirect (lost productivity, 
absenteeism, etc.) costs, respectively [83]. In the current economic context, variables related to health 
management and the cost-benefit ratio are particularly relevant to health policies and clinical protocols, 
and, thus, to action guidelines. Current recommendations highlight the importance of dietary 
counseling in clinical practice. Even though the MedDiet is a diet with a high fat intake, and fat 
sources are derived primarily from monounsaturated oils, in their last guideline on T2DM,  
pre-diabetes, and CVD [6], the European Society of Cardiology together with the European 
Association for the Study of Diabetes group (ESC/EASD) stated, that the MedDiet is an acceptable 
alternative to the traditionally proposed DASH diets, which are mostly prescribed in clinical practice 
today. Besides, ESC/EASD support the consideration that T2DM treatment and prevention should be 
firmly based on complex and non-pharmacological therapies [84]. The ADA 2013 nutrition therapy 
recommendations provide a summary of strong scientific evidence supporting the effectiveness of 
nutrition therapy across the continuum of diabetes management [84], which has reported that non-drug 
treatment is as effective as hypoglycemic drug-treatment, involving a mean reduction of 1.0%–1.5% in 
HbA1c [84]. The role of nutrition in the prevention of CVD has been extensively reviewed [85–87] 
and strong evidence of the influence of dietary factors in atherogenesis both directly and through 
effects on traditional risk factors, such as lipid profile, blood pressure or plasma glucose concentration 
has been reported [88]. Thus, management of obesity and prevention of CVD and T2DM should be 
aimed at reducing the overall risk of cardiodiabesity in a holistic manner. 
Despite the beneficial effects of the MedDiet, there are discrepancies among nutrition experts 
because of the high-fat content of this diet (up to >40% of total energy intake), which is in conflict 
with the usual recommendation to follow a low-fat diet in order to avoid overweight/obesity and to 
prevent CHD [89–91]. A recent meta-analysis [92] argued that current evidence does not clearly 
support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and 
low consumption of total saturated fats. However, it should be remarked that the PREDIMED trial 
demonstrated with the highest level of scientific evidence that the MedDiet is a useful tool to prevent 
CVD end-points in high-risk subjects [46]. On the other hand, the higher palatability, acceptance and 
compliance with MedDiets in comparison with low-fat diets should also be taken into account [93]. 
This review shows that most of the diet-related risk factors of cardiodiabesity may be preventable 
through healthy lifestyles and specifically with a healthy dietary pattern. Note that all the studies 
included took into account the physical activity of the participants but no study undertook active 
intervention controlling of this variable. Thus, all evidence on the reported beneficial effect was 
mainly due to the overall composition of the dietary pattern, without other lifestyle changes. 
Preventive medicine should be part of current and future public health strategies in the global context 
of high rates of chronic diseases around the world. Nowadays, important cultural and economic 
changes are affecting the population lifestyle, and consequently its health. In recent decades, there has 
been a strong social transformation that has led to poorer food habits, a decline in traditional customs 
and a change in the MedDiet pattern [48,91,94]. Promotion of a healthy lifestyle can be used for the 
Nutrients 2014, 6 3493 
 
prevention or treatment of several factors contributing to cardiodiabesity and lead to the avoidance of 
progression and the need for pharmacological interventions. The Spanish Society of Family and 
Community Medicine (SEMFYC) agrees that there is sufficient evidence on the benefits of the dietary 
advice carried out by trained personnel on the prevention of several chronic diseases, but, on the other 
hand, there is little evidence on the effectiveness of dietary advice in primary care, probably due to 
inadequate dietary assessment and other factors. Thus, the dietary advice targeted at apparently healthy 
or low-risk asymptomatic individuals should be simple and easy to comply with [95]. The new 
MedDiet pyramid [18] is the result of an international consensus based on the latest scientific evidence 
on nutrition and health, and provides key elements for the quantitative and qualitative selection of 
foods. This new MedDiet pyramid is meant for use and promotion without any restrictions, and the 
nutritional recommendations based on a MedDiet pattern may lead to the prevention of chronic 
diseases, especially if dietary recommendations take into account individual preferences, thereby 
ensuring long-time adherence. In this sense, the MedDiet could be translated into daily clinical primary 
care practice in the setting of public health promotion programs. In order to facilitate this step and 
achieve greater compliance with dietary advice, the development of the following points should be 
taken into account: 
(i) To develop simple, objective and useful tools to determine the degree of patient adherence 
to the MedDiet pattern for its application in the clinical setting and general practice. 
(ii) To establish consensual recommendations about the MedDiet pattern and psychological 
approaches to eating habits and lifestyle improvements. Moreover, it is important to foster 
knowledge of and accessibility to this dietary pattern to health professionals, particularly in 
primary care where preventive medicine is of greatest, albeit not exclusive, significance. 
Multidisciplinary approaches and strategies are needed to increase compliance to treatments 
and even dietary and lifestyle interventions [96]. 
5. Conclusions 
Most of the reviewed studies provided strong evidence on the association between adherence to a 
MedDiet and CDV, T2DM, MetS and obesity, remarking the relationship between all these 
interconnected illnesses and supporting the term cardiodiabesity. The results of the current review of 
epidemiological and clinical trial studies support the role of the MedDiet in the prevention of 
cardiodiabesity. The prevention of cardiodiabesity by good adherence to the MedDiet is supported by 
the latest most solid scientific evidence, and further by its low environmental footprints and economic 
accessibility in Mediterranean countries. Furthermore, the high palatability of the MedDiet makes this 
dietary pattern very useful for preventive strategies applied to the general population in primary care 
medicine for optimal collaborative management of these patients. 
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